or Try an Advanced Search...

    Technical Analysis for ASRT - Assertio Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 1.19 -4.03% -0.05
    ASRT closed down 4.03 percent on Monday, July 1, 2024, on approximately normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Up
    Historical ASRT trend table...
    Date Alert Name Type % Chg
    200 DMA Resistance Bearish 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Fell Below 200 DMA Bearish -4.03%
    Volume Surge Other -4.03%
    Wide Range Bar Range Expansion -4.03%
    Upper Bollinger Band Walk Strength -4.03%
    Outside Day Range Expansion -4.03%
    Older End-of-Day Signals for ASRT ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 6 hours ago
    Down 2 % about 8 hours ago
    Down 1% about 8 hours ago
    60 Minute Opening Range Breakdown about 8 hours ago
    200 DMA Resistance about 10 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ASRT Chart by TradingView
    Basic chart:

    Profile

    Assertio Therapeutics, Inc. Description

    Assertio Therapeutics, Inc. is a specialty pharmaceutical company. The Company focuses on pain and other central nervous system (CNS) conditions. Its products include NUCYNTA ER (tapentadol extended release tablets), NUCYNTA IR (NUCYNTA) (tapentadol), Gralise (gabapentin), Cambia (diclofenac potassium for oral solution), Xartemis XR and Zipsor (diclofenac potassium). Its NUCYNTA ER (tapentadol extended release tablets) is a product for the management of pain severe enough to require daily long term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults, and its NUCYNTA (tapentadol) is a product for the management of moderate to severe acute pain in adults. Its Gralise (gabapentin) is a once-daily product for the management of postherpetic neuralgia (PHN). Its Cambia (diclofenac potassium for oral solution) is a product for the acute treatment of migraine attacks.

    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Pharmaceutical Organ Systems Pain Organic Compounds Chemical Compounds Opioids Potassium Analgesics Acute Pain Neuropathic Pain Migraine Peripheral Neuropathy Amino Acids Diabetic Peripheral Neuropathy Treatment Of Migraine Postherpetic Neuralgia

    Is ASRT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 27 Assertio: An Extremely Asymmetric Bet Skewed To The Upside
    Jun 13 Assertio Holdings And 2 Other Penny Stocks Insiders Are Buying
    Jun 11 Sidoti Events, LLC's Virtual June Small-Cap Conference
    Jun 7 Neuronetics And 3 Other Stocks Under $3 Insiders Are Buying
    Jun 6 Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
    Jun 5 Assertio to Participate in the Sidoti Small Cap Conference on June 12, 2024
    May 30 Russell 3000: Inovio, Ocugen among healthcare additions; Assertio, Ginkgo Bioworks among deletions
    May 29 Assertio names Brendan O’Grady as its new CEO
    May 29 Assertio Announces the Appointment of Brendan P. O’Grady as New CEO
    May 17 Assertio to Participate in Benchmark Healthcare Conference on May 21-22
    See more ASRT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.78
    52 Week Low 0.7324
    Average Volume 1,085,730
    200-Day Moving Average 1.27
    50-Day Moving Average 1.03
    20-Day Moving Average 1.10
    10-Day Moving Average 1.18
    Average True Range 0.10
    RSI (14) 58.51
    ADX 35.95
    +DI 26.71
    -DI 6.50
    Chandelier Exit (Long, 3 ATRs) 1.12
    Chandelier Exit (Short, 3 ATRs) 1.21
    Upper Bollinger Bands 1.30
    Lower Bollinger Band 0.91
    Percent B (%b) 0.73
    BandWidth 35.27
    MACD Line 0.06
    MACD Signal Line 0.05
    MACD Histogram 0.0133
    Fundamentals Value
    Market Cap 112.66 Million
    Num Shares 94.7 Million
    EPS -2.74
    Price-to-Earnings (P/E) Ratio -0.43
    Price-to-Sales 0.45
    Price-to-Book 0.39
    PEG Ratio 1.20
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.37
    Resistance 3 (R3) 1.39 1.35 1.34
    Resistance 2 (R2) 1.35 1.30 1.34 1.33
    Resistance 1 (R1) 1.27 1.28 1.25 1.25 1.32
    Pivot Point 1.23 1.23 1.22 1.22 1.23
    Support 1 (S1) 1.15 1.18 1.13 1.13 1.06
    Support 2 (S2) 1.11 1.16 1.10 1.05
    Support 3 (S3) 1.03 1.11 1.04
    Support 4 (S4) 1.01